Soluble factors involved in glioma invasion

Acta Neurochirurgica

Volumn 145, Issue 11, 2003, Pages 999-1008

  Mueller, M M ^a   Werbowetski, T ^b   Del Maestro, R F ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Glioma; Growth factor; Invasion

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; NERVE GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; PLASMIN; PROTEINASE; SCATTER FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TYROSINE KINASE RECEPTOR; UROKINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; AUTOCRINE EFFECT; CANCER INVASION; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GLIOMA; HUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR CELL; TUMOR GROWTH; TUMOR SPHEROID; UPREGULATION;

ANIMALS; BRAIN NEOPLASMS; GLIOMA; GROWTH SUBSTANCES; HUMANS; NEOPLASM INVASIVENESS;

EID: 0344441806     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00701-003-0132-0     Document Type: Review

References (98)

1. Aguste P, Gürsel DB, Lemière S, Reimers D, Cuevas P, Carceller F, Di Santo JP, Bikfali A (2001) Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Cancer Res 61: 1717-1726
2. Baskin DG, Wilcox BJ, Figlewicz DP, Dorsa DM (1988) Insulin and insulin like growth factors in the CNS. Trends Neurosci 11: 107-111
3. Bjerkvig R, Laerum OD, Mella O (1986) Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res 46: 4071-4079
4. Bolteus AJ, Berens ME, Pilkington GJ (2001) Migration and invasion in brain neoplasms. Curr Neurol Neurosci Reports 1: 225-232
5. Borgstrom P, Hillan KJ, Sriramarao P, Ferrara N (1996) Complete inhibition of angiogenesis and growth of micro-tumours by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56: 4032-4039
6. Braulke T (1999) Type-2 IGF receptor: a multi-ligand binding protein. Horm Metab Res 31: 242-246
7. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Ceresh DA (1995) Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96: 1815-1822
8. Burke D, Wilkes D, Blundell TL, Malcom S (1998) Fibroblast growth factor receptors: lessons from the genes. Trends Biochem Sci 23: 59-62
9. Chakravarti A, Loeffler JS, Dyson NJ (2002) Insulin-like growth factor receptor mediates resistance to anti-epidermal growth factor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signalling. Cancer Res 62: 200-207
10. Chicoine MR, Madsen C, Silbergeld DL (1995) Modification of human glioma locomotion in vitro by cytokines EGF, bFGF, PDGFbb. NGF, and TNFα. Neurosurgery 36(6): 1165-1171
11. Chu CT, Everiss KD, Wikstrand CJ, Batra SK, Kung HJ, Bigner D (1997) Rezeptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII). Biochem J 324: 855-861
12. Cohen S (1962) Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237: 1555-1562
13. Collins VP (1995) Gene amplification in human gliomas. Glia 15: 289-296
14. Connolly DT, Stoddard BL, Harakas NK, Feder J (1987) Human fibroblast-derived growth factor is a mitogen and chemoattractant for endothelial cells. Biochem Biophys Res Commun 144: 705-712
15. Del Maestro RF, Tamaki M, McDonald W, Amberger VR (1997) The C6 astrocytoma spheroid invasion model: evidence for the presence of a glial-repellent factor(s). Can J Neurol Sci [Suppl] 24: S18 (abstract)
16. Deryugina EI, Soroceanu L, Strongin AY (2002) Up-regulation of vacular endothelial growth factor by membrane-type-1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res 62: 580-588
17. Dhandapani KM, Wade MF, Mahesh VB, Brann DW (2002) Basic fibroblast growth factor induces TGF-β release in an isoform and glioma-specific manner. Neuroreport 13: 239-241
18. Dodd J, Jessell TM (1988) Axon guidance and the patterning of neural projections in vertebrates. Science 242: 692-699
19. Ekstrand AJ, Liu L, He J, Hamid ML, Longo N, Collins VP, James CD (1995) Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor. Oncogene 10: 1455-1460
20. Engebraaten O, Bjerkvig R, Pedersen PH, Laerum OD (1993) Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain tumour biopsies in vitro. Int J Cancer 53: 209-214
21. Glick RP, Lichtor T, Unterman TG (1997) Insulin-like growth factors in central nervous system tumors. J Neuro-Oncol 35: 315-325
22. Goodman C, Shatz C (1993) Developmental mechanisms that generate precise patterns of neuronal connectivity. Cell 72/Neuron [Suppl] 10: 65-75
23. Goldbrunner RH, Berstein JJ, Tonn J-C (1999) Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir (Wien) 141: 295-305
24. Hamasuna R, Kataoka H, Moriyama T, Itoh H, Seiki M, Koono M (1999) Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Int J Cancer 82: 274-281
25. Hamel W, Westphal M (2000) Growth factors in gliomas revisited. Acta Neurochir 142: 113-138
26. Hamel W, Westphal M, Szonyi E, Escandon E, Nikolics K (1993) Neurotrophin gene expression by cell lines derived from human gliomas. J Neurosci Res 34: 147-157
27. Hao C, Parney IF, Roa WH, Turner J, Petruk KC, Ramsay DA (2002) Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathol 103: 171-178
28. Heldin CH (1995) Dimerization of cell surface receptors in signal transduction. Cell 80: 213-223
29. Herold-Mende C, Steiner H-H, Andl T, Riede D, Buttler A, Reisser C, Fusenig NE, Mueller MM (1999) Expression and functional role of VEGF receptors in human tumor cells. Lab Invest 79: 1573-1582
30. Higashiyama S, Abraham JA, Miller JL, Fiddes JC, Klagsbrun M (1991) A heparin-binding growth factor secreted by macrophage-like cell that is related to EGF. Science 251: 936-939
31. Hirohito Y, Hara A, Murase S, Hayashi K, Ando H, Shinoda J, Shimokawa K, Noboru S (2001) Expression of hepatocyte growth factor and matrix metalloproteinase-2 in human glioma. Brain Tumor Pathol 18: 7-12
32. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP (2000) Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 6: 2104-2119
33. Janowska-Wieczorek A, Marquez LA, Nabholtz J-M, Cabuhat ML, Montaño J, Chang H, Rozmus J, Russell JA, Edwards DR, Turner AR (1999) Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34+ cells and their transmigration through reconstituted basement membrane. Blood 93: 3379-3390
34. Kasza A, Kowanetz M, Poslednik K, Witek B, Kordula T, Koj A (2001) Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of the plasminogen activation system in U373-MG astrocytoma cells. Cytokine 16: 187-190
35. Kaufmann K, Thiel G (2001) Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc finger transcription factor, in human malignant glioma cells. J Neurol Sci 189: 83-91
36. Kennedy TE, Serafini T, de la Torre JR, Tessier-Lavigne M (1994) Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord. Cell 78(3): 425-435
37. Khan KM, Falcone DJ, Kraemer R (2002) Nerve growth factor activation of Erk-1 and Erk-2 induces matrix metalloproteinase-9 expression in vascular smooth muscle cells. J Biol Chem 277: 2353-2359
38. Kleihues P, Ohgahki H (1997) Genetics of glioma progression and the definition of primary and secondary glioblastomas. Brain Pathol 7: 1131-1136
39. Kohn EC, Liotta LA (1995) Molecular insights into cancer invasion: Strategies for prevention and intervention. Cancer Res 55: 1856-1862
40. Kondapaka SB, Fridman R, Reddy KB (1997) Epidermal growth factor and amphiregulin up-regulated matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int J Cancer 70: 722-726
41. Koocheckpour S, Merzak A, Pilkington GJ (1995) Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines. Eur J Cancer 31: 375-380
42. Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ, Grogan T, Marquez LA, Janowska-Wieczorek A (1999) Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 94: 2080-2089
43. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA (1989) Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86: 9193-9197
44. Kubota Y, Oka S, Nakagawa S, Shirasuna K (2002) Interleukin-1alpha enhances type I collagen-induced activation of matrix metalloproteinase-2 in odontogenic keratocyst fibroblasts. J Dent Res 81: 23-27
45. Lamoreaux WJ, Fitzgerald MEC, Reiner A, Hasty KA, Charles ST (1998) Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitors of metalloproteinases by microvascular endothelial cells in vitro. Microvascular Res 55: 29-42
46. Lamszus K, Laterra J, Westphal M, Rosen EM (1999) Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int J Dev Neurosci 17: 517-530
47. Lamszus K, Schmidt NO, Jin L, Laterra J, Zagzag D, Way D, Witte M, Weinand M, Goldberg ID, Westphal M, Rosen EM (1998) Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer 75: 19-28
48. Lemmon MA, Schlessinger J (1994) Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem Sci 19: 459-463
49. Merzak A, McCrea S, Koocheckpour S, Pilkington GJ (1994) Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. Br J Cancer 70: 199-203
50. Metcalf D (1985) The granulocyte-macrophage colony-stimulating factors. Science 229: 16-22
51. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579
52. Miyake K, Kimura S, Nakanishi M, Hisada A, Hasegawa M, Nagao S, Abe Y (2000) Transforming growth factor beta-1 stimulates contraction of human glioblastoma cell-mediated collagen lattice through enhanced alpha2 integrin expression. J Neuropathol Exp Neurol 59: 18-28
53. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83: 7297-7301
54. Mori T, Tatsuya A, Wakabayashi Y, Hikawa T, Matsuo K-I, Yamada Y, Kuwano M, Hori S (2000) Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-α or basic fibroblast growth factor. J Neuro-Oncol 46: 115-123
55. Moriyama T, Kataoka H, Hamasuna R, Nakano S, Koono M, Wakisak S (1999b) Up-regulation of urokinase type plasminogen activator and u-PA receptor by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Clin Exp Metast 17: 873-879
56. Moriyama T, Kataoka H, Koono M, Wakisaka S (1999) Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (review). Int J Mol Med 3: 531-536
57. Mueller MM, Herold-Mende CC, Riede D, Lange M, Steiner H-H, Fusenig NE (1999) Autocrine growth regulation by G-CSF and GM-CSF in human gliomas with tumor progression. Am J Pathol 155: 1557-1567
58. Mueller MM, Peter W, Mappes M, Huelsen A, Steinbauer H, Boukamp P, Vaccariello M, Garlick J, Fusenig NE (2001) In vivo microenvironment promotes tumor progression of skin carcinomas by clonal selection and mutagenesis. Am J Pathol 159: 1567-1579
59. Murali R, Brennan PJ, Kieber-Emmons T, Greene MI (1996) Structural analysis of p185c-neu an epidermal growth factor receptor tyrosine kinase: oligomerization of kinase domains. Proc Natl Acad Sci USA 93: 6252-6257
60. Neubauer K, Krüger M, Qondamatteo F, Knittel T, Siale B, Ramadori G (1999) Transforming growth factor-β1 stimulates the synthesis of basement membrane protein laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. J Hepathol 31: 692-702
61. Nitta T, Sato K, Allegretta M, Brocke S, Lim M, Mitchell DJ, Steinman L (1992) Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens. Brain Res 571: 19-25
62. O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA (2000) Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous Carcinoma Cells. Cancer Res 60: 1121-1128
63. Ostrovsky O, Berman B, Gallagher J, Mulloy B, Fernig DG, Delehedde M, Ron D (2002) Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J Biol Chem 277: 2444-2453
64. Paulus W, Baur I, Huettner C, Schmaußer B, Roggendorf W, Schlingensiepen H, Brysch W (1995) Effects of transforming growth factor-beta 1 on collagen synthesis, integrin expression, adhesion and invasion of glioma cells. J Neuropathol Exp Neurol 54: 236-244
65. Pham CD, Roberts TP, van Bruggen N, Melnyk O, Mann J, Ferrara N, Cohen RL, Brasch RC (1998) Magnetic resonance imaging detects suppression of tumour vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 16: 225-230
66. Pilkington GJ, Dunan JR, Rogers JP, Clarke TM, Knott JCA (1993) Growth factor modulation of surface ganglioside expression in cloned neoplastic glia. Neurosci Lett 149: 1-5
67. Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Upregulation of vascular endothelial growth factor and its cognate receptor in a rat glioma model of angiogenesis. Cancer Res 53: 5822-5827
68. Platten M, Wick W, Wild-Bode C, Aulwurm S, Dichgans J, Weller M (2000) Transforming growth factor beta 1 (TGF-beta1) and TGF-beta2 promote glioma cell migration via upregulation of alphaV-beta3 integrin expression. Biochem Biophys Res Commun 268: 607-611
69. Platten M, Wick W, Weller M (2001) Malignant glioma biology: role for TGFβ in growth, motility, angiogenesis and immune escape. Microscopy Res Tech 52: 401-410
70. Pei X-H, Nakanishi Y, Takayama K, Yatsunami J, Bai F, Kawasaki M, Wakamatsu K, Tsuruta N, Mizuno K, Hara N (1996) Granulocyte-colony stimulating factor promotes invasion by human lung cancer cell lines in vitro. Clin Exp Metastasis 14: 351-357
71. Pei X-H, Nakanishi Y, Takayama K, Bai F, Hara N (1999) Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer 79: 40-46
72. Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM, Buckley S (1993) Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 366: 473-475
73. Rooprai HK, Rucklidge GJ, Panou C, Pilkington GJ (2000) The effect of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. Br J Cancer 82: 52-55
74. th edn. Williams & Wilkins, Baltimore, pp 83-289
75. Roth W, Weller M (1999) Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives. Cell Mol Life Sci 56: 481-506
76. Saleh M, Stacker SA, Wilks AF (1996) Inhibition of growth of C6 glioma cell in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393-401
77. Sasaki A, Ishiuchi S, Kanda T, Hasegawa M, Nakazato Y (2001) Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts, and glioblastoma cell lines. Brain Tumor Pathol 18: 13-21
78. Schmidt NO, Westphal M, Hagel C, Ergün S, Stavrou D, Rosen EM, Lamszus K (1999) Level of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogensis. Int J Cancer 84: 10-18
79. Shing Y, Cristofori G, Hanahan D, Ono Y, Sasada R, Igarashi K, Folkman J (1993) Betacellulin: a mitogen from pancreatic β cell tumors. Science 259: 1604-1607
80. Shoyab M, McDonald VL, Bradley G, Todaro GT (1988) Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate-treated human breast adenocarcinoma cell line MCF-7. Proc Natl Acad Sci USA 85: 6528-6532
81. Stefanik DF, Rizkalla LR, Soi A, Goldblatt SA, Rizkalla WM (1991) Acidic and basic fibroblast growth factor are present in glioblastoma multiforme. Cancer Res 52: 5760-5765
82. Steiner H-H, Karcher S, Mueller MM, Nalbantis E, Kunze S, Herold-Mende C (2003) Autocrine pathways of the Vascular Endothelial Growth Factor (VEGF) in glioblastoma multiforme: Clinical relevance of radiation-induced increase of VEGF levels. J Neuro-Oncol (in press)
83. Tamaki M, McDonald W, Amberger V, Moore E, Del Maestro RF (1997) Implantation of C6 astrocytoma spheroid into collagen type I gels: invasive, proliferative, and enzymatic characterizations. J Neurosurg 87: 602-609
84. Todaro GJ, De Larco JE, Cohen S (1976) Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature 264: 26-31
85. Toyoda H, Komurasaki T, Ikeda Y, Yoshimoto M, Morimoto S (1995) Molecular cloning of mouse epiregulin, a novel epidermal growth factor-related protein, expressed in the early stage of development. FEBS Lett 377: 403-407
86. Tsuzuki H, Fujieda S, Sunaga H, Noda I, Saito H (1998) Expression of granulocyte colony stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma. Cancer Res 58: 794-800
87. Vajkoczy P, Menger MD, Vollmar B, Schilling L, Schmiedeck P, Hirth KP, Ullrich A (1999) Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy. Neoplasia 1: 31-41
88. Vajkoczy P, Menger MD, Goldbrunner R, Ge S, Fong AT, Vollmar B, Schilling L, Ullrich A, Hirth KP, Tonn JC, Schmiedeck P, Rempel SA (2000) Trageting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC. Int J Cancer 87: 261-268
89. Van Meir E, Sawamura Y, Diserens AC, Hamou MF, de Tribolet N (1990) Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 50: 6683-6688
90. Wang Y, Hagel C, Hamel W, Muller S, Kluwe L, Westphal M (1998) Trk A, B, and C are commonly expressed in human oligodendrocytes and oligodendroglioma. Acta Neuropathol 96: 357-364
91. Weiss C, Wiesenhofer B, Humpel C (2002) Nerve growth factor plays a divergent role in mediating growth of C6 rat glioma cells via binding to the p75 neurotrophin receptor. J Neuro-Oncol 56: 59-67
92. Welch WC, Kornblith PL, Michalopoulos GK, Petersen BE, Beedle A, Gollin SM, Goldfarb RH (1999) Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells. Anticancer Res 19: 1635-1640
93. Westphal M, Meima L, Szonyi E, Lofgren J, Meissner H, Hamel W, Nikolics K, Sliwkowski MX (1997) Heregulins and the ErbB2/3/4 receptors in gliomas. J Neuro-Oncol 35: 335-346
94. Wick W, Platten M, Weller M (2001) Glioma cell invasion: regulation of metalloproteinase activity by TGF-β. J Neuro-Oncol 53: 177-185
95. Yamada N, Kato M, Yamashita H, Nister N, Miyazono K, Heldin CH, Funa K (1995) Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma. Int J Cancer 62: 386-392
96. Yamahata H, Takeshima H, Kuratsu J-I, Sarker KP, Tanioka K, Waikimaru N, Nakata M, Kitajima I, Maruyama I (2002) The role of thrombin in the neo-vascularization of malignant gliomas: An intrinsic modulator for the up-regulation of vascular endothelial growth factor. Int J Oncol 20: 921-928
97. Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D (2001) Multiple signalling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta 1 in human breast cancer cells. Oncogene 20: 8066-8074
98. Zhang Y, McCluskey K, Fujii K, Wahl LM (1998) Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-α, granulocyte-macrophage CSF, and IL-1β through prostaglandin-dependent and -independent mechanisms. J Immunol 161: 3071-3076